Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4859206

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Oc1ccccc1-c1nc(-c2ccc(C(F)(F)F)cc2)no1

Basic Information

ChEMBL ID CHEMBL4859206
Phase Preclinical
Structure Type MOL
InChI Key BPZMTSRVPSGZIV-UHFFFAOYSA-N
8
Targets
12
Activities
2
Assay Types
0
PK Parameters
12
Publications
0
Known Names

Molecular Properties

306.2
MW (Da)
4.13
ALogP
4
HBA
1
HBD
59.1
PSA (Ų)
0.77
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C15H9F3N2O2
MW 306.24
Aromatic Rings 3
Heavy Atoms 22
NP-Likeness -1.39

Activity Summary

IC50 11 meas. best 8.04
EC50 1 meas. best 7.2

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Thioredoxin reductase 1, cytoplasmic
CHEMBL1927
IC50 8.04 8.04 9.2 2
Inhibitor of nuclear factor kappa-B kinase subunit alpha
CHEMBL3476
IC50 7.98 7.975 10.6 2
NADPH oxidase 4
CHEMBL1250375
IC50 7.97 7.97 10.7 2
Caco-2
CHEMBL614058
IC50 7.86 7.86 13.9 1
HepG2
CHEMBL395
IC50 7.83 7.83 14.9 1
MDA-MB-231
CHEMBL400
IC50 7.21 7.21 61.8 1
No relevant target
CHEMBL2362975
EC50 7.2 7.2 63.0 1
WI-38
CHEMBL614391
IC50 6.45 6.45 352.3 1
No relevant target
CHEMBL2362975
IC50 6.37 6.37 423.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Thioredoxin reductase 1, cytoplasmic IC50 = 9.21 nM 8.04 Inhibition of TrxR1 (unknown origin) assessed as reduction in DTNB to TNB by col... 33901898
Thioredoxin reductase 1, cytoplasmic IC50 = 9.226 nM 8.04 Inhibition of TrxR1 (unknown origin) assessed as reduction in DTNB to TNB by col... 33901898
Inhibitor of nuclear factor kappa-B kinase subunit alpha IC50 = 10.58 nM 7.98 Inhibition of IKKalpha (unknown origin) by ADP-Glo kinase assay 33901898
Inhibitor of nuclear factor kappa-B kinase subunit alpha IC50 = 10.59 nM 7.97 Inhibition of IKKalpha (unknown origin) by ADP-Glo kinase assay 33901898
NADPH oxidase 4 IC50 = 10.71 nM 7.97 Inhibition of human NADPH oxidase 4 by quantitative sandwich enzyme immunoassay ... 33901898
NADPH oxidase 4 IC50 = 10.72 nM 7.97 Inhibition of human NADPH oxidase 4 by quantitative sandwich enzyme immunoassay ... 33901898
Caco-2 IC50 = 13.9 nM 7.86 Anticancer activity against human Caco-2 cells assessed as reduction in cell via... 33901898
HepG2 IC50 = 14.9 nM 7.83 Anticancer activity against human HepG2 cells assessed as reduction in cell viab... 33901898
MDA-MB-231 IC50 = 61.8 nM 7.21 Anticancer activity against human MDA-MB-231 cells assessed as reduction in cell... 33901898
No relevant target EC50 = 63.0 nM 7.2 Metal chelating activity of the compound assessed as decrease in the Fe2+-phenan... 33901898
WI-38 IC50 = 352.3 nM 6.45 Cytotoxicity against human WI-38 cells assessed as reduction in cell viability a... 33901898
No relevant target IC50 = 423.0 nM 6.37 Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins ... 33901898

Literature References

PubMed DOI Target Context # Activities
33901898 10.1016/j.ejmech.2021.113475 HepG2 6
33901898 10.1016/j.ejmech.2021.113475 MDA-MB-231 5
33901898 10.1016/j.ejmech.2021.113475 Caco-2 5
33901898 10.1016/j.ejmech.2021.113475 Unchecked 3
35390713 10.1016/j.ejmech.2022.114315 PC-12 3
33901898 10.1016/j.ejmech.2021.113475 No relevant target 2
33901898 10.1016/j.ejmech.2021.113475 WI-38 2
33901898 10.1016/j.ejmech.2021.113475 ADMET 2
33901898 10.1016/j.ejmech.2021.113475 Nuclear factor erythroid 2-related factor 2 2
33901898 10.1016/j.ejmech.2021.113475 Thioredoxin reductase 1, cytoplasmic 2
33901898 10.1016/j.ejmech.2021.113475 Inhibitor of nuclear factor kappa-B kinase subunit alpha 2
33901898 10.1016/j.ejmech.2021.113475 NADPH oxidase 4 2

Data from ChEMBL 36 via Core Engine